您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

王正旭醫師

內科學、細胞治療、癌症腫瘤醫學、癌症治療、安寧療護、安寧照顧、臨床醫學教育、醫病關係、臨床試驗、基礎研究
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 長庚紀念醫院基隆院區血液腫瘤科兼任主治醫師
    • 長庚醫院教授
  • 學歷
    • 陽明大學公共衛生研究所(法律與政策組) 博士
    • 中國醫藥大學 醫學系
  • 經歷
    • 長庚醫療財團法人基隆長庚紀念醫院血液腫瘤科 主任
    • 長庚醫療財團法人基隆長庚紀念醫院臨床試驗中心 主任
    • 基隆長庚醫院癌症中心主任
    • 榮獲第五屆國家公益獎團體獎
    • 長庚紀念醫院基隆分院內科部部長
    • 基隆長庚醫院醫學教育委員會主席
    • 中華民國癌症醫學會監事主席
    • 前HOPE癌症希望基金會董事長
  • 學會與認證
    • 台灣內科醫學會
    • 中華民國癌症醫學會
    • 台灣安寧緩和醫學會
    • 台灣乳房醫學會
  • 論文及期刊發表
    • Early nutritional support in non-metastatic stage IV oral cavity cancer patients undergoing adjuvant concurrent chemoradiotherapy: analysis of treatment tolerance and outcome in an area endemic for betel quid chewing.
      Support Care Cancer. 2012 Jun; 20:1169–1174
      Wang CH, Wang HM, Pang YP, Yeh KY.
    • Unusual hematogenous brain metastasis in malignant fibrous histiocytoma of the maxillary sinus.
      Int J Clin Oncol. 2012 Feb; 17(1): 69-74
      Wu TH, Shih CW, Huang JS, Wang CH, Yeh KY.
    • Chang Gung Med J. 2011 Sep-Oct;34(5):478-86.
      Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma.
      Su PJ, Chen JS, Liaw CC, Chang HK, Wang HM, Yang TS, Lin YC, Liau CT, Yang HY, Yeh KY, Ho MM, Chang NJ, Wang CH, Chang JW.
    • Hypersensitivity Reaction to Oxaliplatin.
      J. Cancer Res. Pract.2011;27(5):222-226
      Pei-Hung Chang, Yen-Min Huang, Yueh-Shih Chang, Cheng-Hsu Wang, Jeng-Seng Huang.
    • Oxaliplatin-Induced Coronary Vasospasm Manifesting As Kounis Syndrome: A Case Report.
      J Clin Oncol. 2011 Oct ;29:776-778
      Chang PH, Hung MJ, Yeh KY, Yang SY, Wang CH*.
    • Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression.
      Anticancer Drugs. 2011 Jan;22(1):89-98.
      Li YY, Chang JW, Liu YC, Wang CH, Chang HJ, Tsai MC, Su SP, Yeh KY.
    • Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
      Head Neck. 2011 May;33(5):734-42.
      Yeh KY, Chang JW, Li YY, Wang CH, Wang HM.
    • Comparison of Physician and Healthcare Worker Performance during a Small Group Evidence-Based Workshop.
      Journal of Medical Education. 2010 March; 14(1): 49-57
      Chung-Han Yang, Yung-Chih Chen, Ning-I Yang,Jhao-Ning Shin, Kuang-Hui Yu, Cheng-Hsu Wang.
    • The Effect of Early Nutritional Intervention on Postoperative Oral Cavity Cancer Patients Undergoing Concurrent Chemoradiotherapy.
      Journal of Living Sciences.14: 153-172, 2010
      Kun-Yun Yeh Yi-Ping Pang Cheng-Hsu Wang.
    • Long-term survivors of adult rhabdomyosarcoma of maxillary sinus following multimodal therapy: case reports and literature reviews.
      Chang Gung Med J. 33: 466-71,2010.
      Tsung-Han Wu, Jen-Seng Huang, Hung-Ming Wang, Cheng-Hsu Wang, Kun-Yun Yeh.
    • Long-term survival after surgery for stage III-IV maxillary sinus carcinoma.
      B-ENT.6:35-41,2010
      Wu TH, Huang JS, Wang HM, Chang JW, Song GG, Wang CH, Yeh KY.
    • Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma.
      Melanoma Res. 2009 Oct;19(5):309-15.
      Chang JW, Hsieh JJ, Shen YC, Ho E, Chuang CK, Chen YR, Liao SK, Chen JS, Leong SP, Hou MM, Chang NJ, Wang CH.
    • Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells.
      Cancer Lett. 2009 Jun 8;278(1):17-26.
      Chang JW, Hsieh JJ, Shen YC, Yeh KY, Wang CH, Li YY, Hsu T.
    • Patient awareness of prognosis, patient-family caregiver congruence on the preferred place of death, and caregiving burden of families contribute to the quality of life for terminally ill cancer patients in Taiwan.
      Psycho-Oncology. 17:1202-1209,2008
      Siew Tzuh Tang, Tsang-Wu Liu, Chun-Ming Tsai, Cheng-Hsu Wang, Gee-Chen Chang and Li-Ni Liu.
    • Zoledronic acid is unable to induce apoptosis, but slows trumor growth and prolongs survival for non-small-cell lung cancers.
      Lung Cancer. 59: 180-191, 2008.
      Ying-Ying Li, John W.-C. Chang, Wen-Chi Chou, Chuang-Chi Liaw, Hung-Ming Wang, Jen-Seng Huang, Cheng-Hsu Wang, Kun-Yun Yeh.
    • A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.
      Cancer Chemother Pharmacol. 2008 Apr;61(5):847-53.
      Hong RL, Lin CH, Chao TY, Kao WY, Wang CH, Hsieh RK, Hwang WS.